Follow us on:

Avingtrans acquisition of Transkem a great strategic fit (Interview)

Avingtrans plc (LON:AVG) PSRE Divisional Managing Director Austen Adams joins DirectorsTalk Interviews to discuss the acquisition of Hillington-based Transkem.

Austen explains what the company does, how much it cost, the strategic fit with Avingtrans and if the company will be looking to do more acquisitions in this area.

Avingtrans designs, manufactures and supplies critical components, modules, systems and associated services to the energy, medical and industrial sectors. It has a proven strategy of “buy and build” in highly regulated engineering markets, a strategy it has named “Pinpoint-Invest-Exit”. Significant shareholder value is delivered through a clear strategy, a strong balance sheet and an agile and experienced management team.

You might also enjoy reading Avingtrans CEO Steve McQuillan on Record Growth, Investments and Future Strategies (VIDEO)

Find more news, interviews, share price & company profile here for:

Share this interview

Other Interviews

More News

Avingtrans positive update and possible acquisition of Adaptix July 13, 2023
Avingtrans delivers robust results with group revenue increasing to £50.0m February 22, 2023
Avingtrans Plc Adaptix appoints Willem Baralt as new Chairman February 15, 2023
Avingtrans Adaptix secures 510(k) clearance from FDA January 30, 2023
Avingtrans ownership in Magnetica will increase to 74% January 18, 2023
Avingtrans Plc trading in line with management expectations January 16, 2023
Avingtrans CEO Steve McQuillan appointed as non-executive Chairman of investee Adaptix December 14, 2022
Avingtrans report increased revenue and gross margin September 28, 2022
Avingtrans strong cash position and to be in line with market expectations July 7, 2022
Avingtrans Hayward Tyler, Inc. Secures Two Nuclear Contracts worth $7m April 11, 2022

Search

Useful links

Disclaimer

You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular stock, share, security, portfolio of securities, transaction, investment strategy, or other matter. We openly disclose that we and our contributors may have interests in investments and/or providers of services referred to within the website and that we receive remuneration from certain of the companies referred to on this website.

© 2024 – DirectorsTalk Interviews. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.